Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Chorus (CNU) / FY25

Chorus FY25: equity fell 32.6% as gross debt rose 19.5% on flat earnings

A step-up in free cash flow to $354m did not prevent net debt/EBITDA rising from 3.7x to 4.3x while the dividend was lifted 21.1%.

Telecommunications & Media / Telecommunications infrastructure

CNU revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $506m, versus $1b in FY25.

CNU EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
  • HY24 CNU: Outside range low ebitda margin. 69%; 3-period range 69.2% to 70.6%. EBITDA margin: 69.0%, below normal range; 3-period mean 70.0%, range 69.2%-70.6%.
  • HY26 CNU: Outside range high ebitda margin. 70.6%; 3-period range 69% to 70.2%. EBITDA margin: 70.6%, above normal range; 3-period mean 69.5%, range 69.0%-70.2%.
EBITDA margin: 70.6%, above normal range; 3-period mean 69.5%, range 69.0%-70.2%.

CNU operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $228m, versus $559m in FY25.

CNU working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
FY25 was -$5m, versus $3m in FY24.
Release date
25 August 2025
Published
23 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

FY25 vs FY24

Revenue

$1b

+0.4% ↑ vs $1b

EBITDA

$705m

+0.7% ↑ vs $700m

Net profit after tax

$4m

+144.4% ↑ vs −$9m

Net cash inflow from operating activities

$559m

+9.0% ↑ vs $513m

Final dividend per share

34.5c

+21.1% ↑ vs 28.5c

Cash and cash equivalents

$81m

+80.0% ↑ vs $45m

Total assets

$6.1b

+1.3% ↑ vs $6b

What changed

The headline movement is on the balance sheet, not the P&L

Total equity fell 32.6% to $567.0m, gross borrowings rose 19.5% to $3.1b, and net debt/EBITDA stepped up from 3.69x to 4.34x. Operating performance was essentially flat: revenue +0.4% to $1b, EBITDA +0.7% to $705.0m, and profit before tax unchanged at $21.0m.

NPAT swung from a $9.0m loss to a $4.0m profit (+144.4%), but this is a tax-line story rather than an operating one — the effective tax rate fell from 142.9% to 81.0% on a near-identical PBT.

Cash generation improved sharply: operating cash flow rose to $559.0m and gross capex eased 2.8% to $415.0m, lifting free cash flow from $86.0m to $354.0m. The board declared a 34.5 cps final dividend (FY25 total 57.5 cps), up 21.1% on the prior final.

What matters

Leverage moved decisively higher

  • Despite the $354.0m of free cash flow, gross debt rose $512.0m and equity contracted $274.0m, taking net debt/EBITDA to 4.3x. With EBITDA effectively flat, deleveraging now depends almost entirely on cash discipline rather than earnings growth, and any further dividend or capex step-up would push the leverage ratio higher again.
  • The NPAT print overstates progress. PBT was flat at $21.0m and the +144.4% NPAT move is a function of an 81.0% effective tax rate this year against 142.9% last year. The cleaner read is that group earnings did not grow; investors weighing the result against the dividend lift should anchor on PBT, not NPAT.
  • The dividend was raised while debt funded part of the distribution envelope. FCF coverage of the 34.5 cps final looks comfortable on the 39.0% payout-vs-FCF measure, but the parallel rise in borrowings shows that group cash outflows in aggregate (dividends, lease payments, investment) still exceeded internally generated cash. That tension matters for the durability of the new dividend rate.

Expectations

No FY26 numerical guidance is captured in the supplied disclosures and there are no stated medium-term targets to test the result against

The release cites FY26 guidance and a "Horizon 2" outlook in the presentation, but no numeric anchors flow through to the calculation set.

The half-on-half shape is also unusual: HY25 carried 49.3% of full-year revenue and 49.1% of EBITDA — broadly even — but contributed $5.0m of NPAT against an implied 2H loss of around $1.0m. That suggests second-half operating earnings softened even as cash flow held up, which is worth watching into FY26.

Quality of result

The cash result is the most durable element

OCF/EBITDA rose to 79.3% from 73.3%, capex intensity eased to 40.9% of revenue from 42.3%, and trade debtors fell to 95 days-equivalent of 34.2 (from 36.1). None of the FCF uplift relies on stretching working capital — receivables actually shortened.

The earnings result is lower quality. PBT is flat, NPAT is tax-flattered, and ROE — at 0.7% versus -1.1% — only looks improved because the equity base has shrunk by a third. The combination of a 21.1% higher final dividend, $512.0m of incremental gross borrowings, and a $274.0m equity reduction means the capital structure is doing more work than the income statement to support shareholder returns. Capex at over 40% of revenue also continues to absorb the bulk of operating cash, leaving limited headroom if either EBITDA softens or rates rise on the larger debt stack.

Unresolved

Open questions

Why did total equity fall $274.0m when reported NPAT was a $4.0m profit, and which non-P&L items drove the reduction?
What is the targeted net debt/EBITDA range, and is 4.3x consistent with management's leverage policy?
Will FY26 capex remain near 40% of revenue, and what does the Horizon 2 plan imply for future capex intensity?
Is the new 57.5 cps annual dividend run-rate intended to be funded entirely from FCF, or is partial debt funding now policy?
Why did 2H NPAT swing negative on broadly flat half-on-half revenue and EBITDA, and is that operating mix expected to persist?

This briefing cannot assess the underlying drivers of the equity reduction, the FY26 capex and guidance envelope, or management's stated leverage tolerance, because those disclosures are not present in the supplied materials.

Chat

Ask about CNU FY25

Ask follow-up questions about Chorus's FY25 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about CNU FY25

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Chorus's FY25 result.

Why did total equity fall $274.0m when reported NPAT was a $4.0m profit, and which non-P&L items drove the reduction?Why does "Leverage moved decisively higher" matter?How strong was the cash and earnings quality in FY25?What should I watch next for CNU after FY25?

Checking account...

Data appendix

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

1. Chorus FY25 media release

FY25 / results announcement↗

1. Chorus FY25 media release

FY25 / media release↗

2. Chorus FY25 Investor Presentation

FY25 / results presentation↗

3. Chorus FY25 Annual Report

FY25 / financial report↗

Prior comparable period

Annual Report - FY24

FY24 / financial report↗

Media Release - FY24 results

FY24 / media release↗

NZX Financial Results Announcement - FY24

FY24 / results announcement↗

Interim context

1. Chorus media release HY25

HY25 / media release↗

3. Chorus HY25 Management Commentary and Financial Statements

HY25 / financial report↗

4. HY25 Results Announcement

HY25 / results announcement↗

Related insights

Cross-company views selected from the metrics in this briefing.

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 144.4pp, with a distortion flag in the result.

→

Leverage and balance-sheet risk

Net debt / EBITDA is 4.34x, +0.65x versus the prior comparable period.

→

Cash conversion quality

This result converted 79.3% of EBITDA to operating cash flow, +6.0pp versus the prior comparable period.

→

Dividend coverage and payout pressure

Dividend payout versus pre-lease FCF is 63.0%, with NPAT payout at n/a.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when CNU publishes next

Get the next Chorus briefing and related NZX reporting-season updates by email.